Research Studies on Organ Perfusion: From the Lab to the Clinic
A number of important medical questions cannot be addressed in patients for several reasons. First, the population is often too heterogeneous, with intricate underlying problems. Second, patients are usually seen when the disease state is already established so that the mechanisms of its development cannot be adequately studied and early interventions are impossible. Third, the methods necessary to the study may be too mutilating to be used in patients. In other words, the risk/benefit ratio is often too high for human application.
KeywordsSeptic Shock Methylene Blue Organ Perfusion Stagnant Hypoxia Disease Clinical Trial
Unable to display preview. Download preview PDF.
- 2.Friedman G, Gomez J, Shahla M, Vincent JL (1995) Mortality from septic shock: have we made progress? Am J Respir Crit Care Med 151:A494 (Abstr)Google Scholar
- 7.Zhang H, Rogiers P, Preiser JC, Spapen H, Manikis P, Vincent JL (1995) Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med (in press)Google Scholar